J. Fiorica

发表

Cytology of human ovarian surface epithelial brushings

D. Coppola, P. Kruk, S. Nicosia, 2003, Cancer.

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

J. Krischer, S. Nicosia, R. Sutphen, 2005, Cancer.

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.

J. Fiorica, R. Mannel, V. Brunetto, 2004, Gynecologic oncology.

Lysophospholipids are potential biomarkers of ovarian cancer.

Rebecca Sutphen, Martin Martino, Hector Arango, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy.

J. Fiorica, H. Greenberg, J. Lapolla, 1990 .

PC‐Based Multiparameter Full‐Color Display for Tissue Segmentation in MRI of Adnexal Masses

M. Silbiger, J. Fiorica, C. Berman, 1993, Journal of computer assisted tomography.

Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer.

Domenico Coppola, Lin Yang, D. Coppola, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Surveillance of the endometrium in tamoxifen treated women

R. Cardosi, J. Fiorica, 2000, Current opinion in obstetrics & gynecology.

Uterine junctional zone: correlation between histologic findings and MR imaging.

L. Clarke, S. Nicosia, M. Silbiger, 1991, Radiology.

Hormone Replacement Therapy and Breast Cancer Risk in California

Richard J. K. Taylor, J. Boyages, J. Fiorica, 2005, The breast journal.

Infectious urinary tract morbidity with prolonged bladder catheterization after radical hysterectomy.

R. Cardosi, J. Fiorica, M. Hoffman, 2003, American journal of obstetrics and gynecology.

Tissue Segmentation by Multiparameter Full-Color Composite Techniques: Clinical Application in Magnetic Resonance Imaging of Adnexal Masses

M. Silbiger, J. Fiorica, C. Berman, 1993 .

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Mads Thomassen, Nina Ditsch, Vijai Joseph, 2012, Breast Cancer Research.

Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.

R. McGhee, H. Hricak, L. Schwartz, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Update on the treatment of cervical and uterine carcinoma: focus on topotecan.

J. Fiorica, 2002, The oncologist.

Accuracy of Lymph Node Palpation to Determine Need for Lymphadenectomy in Gynecologic Malignancies

J. Fiorica, M. Hoffman, W. Roberts, 2000, Obstetrics and gynecology.

Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183.

H. Hricak, D. Mitchell, D. Chi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of topotecan in the treatment of advanced cervical cancer.

J. Fiorica, 2003, Gynecologic oncology.

Accuracy of pelvic examination in the assessment of patients with operable cervical cancer.

R. Cardosi, J. Fiorica, M. Hoffman, 2004, American journal of obstetrics and gynecology.

Natural history and clinical evaluation of the lumpectomy scar.

S. Nicosia, R. Clark, D. Reintgen, 1993, The American surgeon.

Diagnosing pulmonary embolism: experience with spiral CT pulmonary angiography in gynecologic oncology.

A. Cantor, R. Cardosi, J. Fiorica, 2005, Gynecologic oncology.

Advances in the prevention and treatment of deep vein thrombosis and pulmonary embolism.

J. Fiorica, E. Grendys, 1999, Current opinion in obstetrics & gynecology.

In vitro chemoresponse in metachronous pairs of ovarian cancers.

B. Monk, M. Shahin, I. Benjamin, 2014, Anticancer Research.

Thyroid Cancer in Pregnancy

T. Padhya, J. Fiorica, S. Athavale, 2007, The Laryngoscope.

In vitro chemoresponse in metachronous pairs of gyneclologic cancers

B. Monk, J. Fiorica, C. McClure, 2014, Gynecologic Oncology Research and Practice.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012, Breast Cancer Research.

Predictive value of combined assays of urinary gonadotropin fragment (UGF) and CA 125 for ovarian carcinoma in patients with pelvic masses

J. Fiorica, N. Gleeson, W. Roberts, 1995 .

Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management.

R. Cardosi, J. Fiorica, M. Martino, 2005, American journal of obstetrics and gynecology.

Cervical cancer screening.

R Kevin Reynolds, Wendy Likes, K. Smith-McCune, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.

D. Miller, J. Fiorica, J. Sorosky, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.

B. Monk, D. Miller, J. Fiorica, 2006, Gynecologic oncology.

A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer.

R. Wenham, I. Vergote, J. Fiorica, 2019, Gynecologic oncology.

Subcutaneous management of vertical incisions with 3 or more centimeters of subcutaneous fat.

R. Cardosi, J. Fiorica, M. Hoffman, 2006, American journal of obstetrics and gynecology.

Invasive carcinoma of the vulva

J. Fiorica, J. Lapolla, M. Hoffman, 1990 .

Ultraradical surgery for advanced carcinoma of the vulva: an update

J. Fiorica, M. Hoffman, W. Roberts, 1993, International Journal of Gynecologic Cancer.

Pudendal thigh fasciocutaneous flaps for vaginal reconstruction in gynecologic oncology.

J. Fiorica, M. Hoffman, N. Gleeson, 1994, Gynecologic oncology.

Bartholin's gland carcinoma: a 15-year experience.

R. Cardosi, J. Fiorica, A. Hakam, 2001, Gynecologic oncology.

Complications of colostomy performed on gynecologic cancer patients.

J. Fiorica, M. Hoffman, M. Finan, 1992, Gynecologic oncology.

Surgical and psychosexual outcome following vaginal reconstruction with pelvic exenteration.

J. Fiorica, M. Hoffman, N. Gleeson, 1994, European journal of gynaecological oncology.

Use of Vicryl mesh in the reconstruction of the pelvic floor following exenteration.

J. Fiorica, M. Hoffman, W. Roberts, 1989, Gynecologic oncology.

Use of local flaps in the preservation of fecal continence following resection of perianal neoplasias

J. Fiorica, M. Hoffman, N. Gleeson, 1992, International Journal of Gynecologic Cancer.

Innovations in the management of vulvar carcinoma

J. Fiorica, Edward C Grendys Jr, 2000, Current opinion in obstetrics & gynecology.

Lateral microscopic extension of squamous cell carcinoma of the vulva.

J. Fiorica, M. Hoffman, D. Cavanagh, 1999, Gynecologic oncology.

The effects of cold therapy on postoperative pain in gynecologic patients: A prospective, randomized study

J. Fiorica, M. Hoffman, M. Finan, 1993 .

Interstitial radiotherapy for the treatment of advanced orrecurrent vulvar and distal vaginal malignancy

J. Fiorica, H. Greenberg, J. Lapolla, 1990 .

Carcinoma of the vulva involving the perianal or anal skin.

J. Fiorica, J. Lapolla, M. Hoffman, 1989, Gynecologic oncology.

Management of radionecrosis of the vulva and distal vagina.

J. Fiorica, J. Lapolla, M. Hoffman, 1991, American journal of obstetrics and gynecology.

Phase II Trial of Trastuzumab in Women with Advanced or Recurrent , HER 2-Positive Endometrial Carcinoma : a Gynecologic Oncology Group Study

J. Berek, J. Fiorica, G. Fleming, 2010 .

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.

J. Berek, J. Fiorica, G. Fleming, 2010, Gynecologic oncology.

Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.

J. Fiorica, M. Hoffman, N. Gleeson, 1993, European journal of gynaecological oncology.

Inherited susceptibility to breast and ovarian cancer.

R. Sutphen, J. Fiorica, T. Diamond, 1998, Current opinion in obstetrics & gynecology.

Experience with the EndoPap device for the cytologic detection of uterine cancer and its precursors: a comparison of the EndoPap with fractional curettage or hysterectomy.

S. Nicosia, J. Fiorica, C. Songster, 1990, American journal of obstetrics and gynecology.

Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study

P. Neven, S. Peacock, N. Urban, 2002 .

Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

B. Monk, J. Fiorica, J. Thigpen, 2004, International Journal of Gynecologic Cancer.

Ileus Following Gynecologic Surgery: Management With Water‐Soluble Hyperosmolar Radiocontrast Material

J. Fiorica, M. Hoffman, N. Gleeson, 1995, Southern medical journal.

Body mass predicts the survival of patients with new international federation of gynecology and obstetrics stage IB1 and IB2 cervical carcinoma treated with radical hysterectomy

J. Fiorica, M. Hoffman, M. Finan, 1998, Cancer.

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.

Gloria S. Huang, S. Pignata, J. Fiorica, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

A. Godwin, A. Sood, M. Shahin, 2012, Gynecologic oncology.

MANAGEMENT OF CHEMOTHERAPY IN A PREGNANCY COMPLICATED BY A LARGE NEUROBLASTOMA

G. Lyman, J. Fiorica, W. Spellacy, 1994, Obstetrics and gynecology.

Urokinase plasminogen activator in ovarian cancer.

J. Fiorica, L. Moscinski, M. Hoffman, 1996, European journal of gynaecological oncology.

Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?

J. Fiorica, M. Hoffman, M. Finan, 1996, Gynecologic oncology.

Treatment of advanced gynecologic malignancies with intraarterial chemotherapy and accelerated fractionation radiation therapy: a preliminary report.

J. Fiorica, H. Greenberg, J. Kavanagh, 1990 .

A Pilot Study Utilizing Intraoperative Lymphoscintigraphy for Identification of the Sentinel Lymph Nodes in Vulvar Cancer

D. Reintgen, J. Fiorica, C. Puleo, 1997 .

Carcinoma in situ of the vulva: 24 years' experience in southwest Florida.

J. Fiorica, J. Shepherd, C. Songster, 1988, Southern medical journal.

Chapter 14 – Breast Diseases

J. Fiorica, 2007 .

Palliative intestinal surgery for patients with carcinoma of the cervix

J. Fiorica, M. Hoffman, N. Gleeson, 1994 .

Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.

J. Fiorica, R. Holloway, J. Lapolla, 2002, Gynecologic oncology.

Radical hysterectomy for treatment of cervical cancer: Aprospective study of two methods of closed-suction drainage

J. Fiorica, M. Hoffman, M. Finan, 1992 .

q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012 .

Consequences of estrogen deprivation and the rationale for hormone replacement therapy.

J. Fiorica, C. Rackley, S. Wysocki, 2000, The American journal of managed care.

A study of autologous dendritic cell therapy targeting mucin-1 for treatment of patients with epithelial ovarian cancer in first remission.

J. Berek, H. Gray, J. Fiorica, 2012 .

Breast Cancer Screening, Mammography, and Other Modalities

J. Fiorica, 2016, Clinical obstetrics and gynecology.

Does ligation of the hypogastric artery at the time of radical hysterectomy and lymphadenectomy decrease blood loss? Results of a prospective randomized trial.

J. Fiorica, M. Hoffman, W. Roberts, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Overview of a chemoresponse assay in ovarian cancer

R. Holloway, J. Chan, J. Fiorica, 2014, Clinical and Translational Oncology.

Upper vaginectomy for the treatment of vaginal intraepithelial neoplasia.

J. Fiorica, M. Martino, M. Hoffman, 2005, American journal of obstetrics and gynecology.

Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina.

J. Fiorica, M. Hoffman, W. Roberts, 1992, American journal of obstetrics and gynecology.

Cervical Conization With Frozen Section Before Planned Hysterectomy

J. Fiorica, M. Hoffman, W. Roberts, 1993, Obstetrics and gynecology.

Severe radiation injury to the sigmoid colon

J. Fiorica, M. Hoffman, W. Roberts, 1996 .

Effectiveness of COVID-19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization With SARS-CoV-2 Infection

W. Wiese-Rometsch, J. Fiorica, R. Mercado, 2021, Cureus.